Bryce A Kerlin

Summary

Affiliation: Nationwide Children's Hospital
Country: USA

Publications

  1. pmc Current and future management of pediatric venous thromboembolism
    Bryce A Kerlin
    Division of Hem Onc BMT, Nationwide Children s Hospital, Columbus, Ohio, USA
    Am J Hematol 87:S68-74. 2012
  2. doi request reprint Venous thromboembolism in pediatric nephrotic syndrome
    Bryce A Kerlin
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA
    Pediatr Nephrol 29:989-97. 2014
  3. pmc Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
    Bryce A Kerlin
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, USA
    Clin J Am Soc Nephrol 7:513-20. 2012
  4. pmc Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study
    Bryce A Kerlin
    Department of Pediatrics, College of Medicine, Ohio State University, Columbus, OH, USA
    J Pediatr 155:105-10, 110.e1. 2009
  5. pmc Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases
    Bhuvana A Setty
    Division of Hem Onc BMT, Nationwide Children s Hospital, Columbus, Ohio, USA
    Pediatr Blood Cancer 59:258-64. 2012
  6. doi request reprint Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience
    Todd J Karsies
    Division of Critical Care, Nationwide Children s Hospital, Columbus, Ohio, USA
    Ann Thorac Surg 89:570-6. 2010

Collaborators

Detail Information

Publications6

  1. pmc Current and future management of pediatric venous thromboembolism
    Bryce A Kerlin
    Division of Hem Onc BMT, Nationwide Children s Hospital, Columbus, Ohio, USA
    Am J Hematol 87:S68-74. 2012
    ..Clinical studies and trials in pediatric VTE are underway which will hopefully improve the quality of evidence from which therapeutic guidelines are derived...
  2. doi request reprint Venous thromboembolism in pediatric nephrotic syndrome
    Bryce A Kerlin
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA
    Pediatr Nephrol 29:989-97. 2014
    ..Observational cohort studies are needed to identify VTE-risk groups who may benefit from thromboprophylaxis and to define disease-specific treatment algorithms. ..
  3. pmc Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
    Bryce A Kerlin
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, USA
    Clin J Am Soc Nephrol 7:513-20. 2012
    ....
  4. pmc Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study
    Bryce A Kerlin
    Department of Pediatrics, College of Medicine, Ohio State University, Columbus, OH, USA
    J Pediatr 155:105-10, 110.e1. 2009
    ..To identify clinical variables predictive of the risk of thromboembolism (TE), and to confirm the incidence of TE in primary and secondary childhood nephrotic syndrome (NS)...
  5. pmc Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases
    Bhuvana A Setty
    Division of Hem Onc BMT, Nationwide Children s Hospital, Columbus, Ohio, USA
    Pediatr Blood Cancer 59:258-64. 2012
    ..Pediatric venous thromboembolism (VTE) is an increasingly common problem. We hypothesized that VTE occurs most commonly in tertiary care settings and that the pattern of associated illnesses may have changed from earlier reports...
  6. doi request reprint Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience
    Todd J Karsies
    Division of Critical Care, Nationwide Children s Hospital, Columbus, Ohio, USA
    Ann Thorac Surg 89:570-6. 2010
    ..Recombinant activated factor seven (rFVIIa) is increasingly being used as a hemostatic adjunct in pediatric cardiac surgery. We evaluated the thrombotic safety profile of rFVIIa in pediatric congenital heart disease (CHD) surgery...